Metraipolis › archive › dc_a052ce08956d

De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis — Europe PMC PMID:40824489

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40824489
DOI
10.1007/s00277-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-07T22:58:14.044Z
SHA-256 of the archived text
855a6b42b692a1450cf4d8b9ef794f55f605e27ab4001bf5bbd17736a727a608
Stable URL of this page
https://metraipolis.com/documento/dc_a052ce08956d

How to cite

De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis — Europe PMC PMID:40824489 — Europe PMC (en), https://europepmc.org/article/MED/40824489 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a052ce08956d (Metraipolis archive dc_a052ce08956d, sha256 855a6b42b692a1450cf4d8b9ef794f55f605e27ab4001bf5bbd17736a727a608)
BibTeX
@misc{dca052ce08956d,
  title = {De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis — Europe PMC PMID:40824489},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40824489},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a052ce08956d; sha256 855a6b42b692a1450cf4d8b9ef794f55f605e27ab4001bf5bbd17736a727a608},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40824489. Agents can read the archived copy with the MCP tool read_document.